Heron Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Heron Therapeutics, Inc. (HRTX)
Last heron therapeutics, inc. earnings: 3/2 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
herontherapeutics.gcs-web.com/investor-home
Company Research
Source: Yahoo! Finance
million , a ~73% gross margin and a refinancing that management said meaningfully de-risked the capital structure. The acute care franchise accelerated in Q4—acute care net sales were $16.3 million (up ~ sequentially), with ZYNRELEF and APONVIE showing strong year-over-year growth—momentum management attributes to initiatives like CrossLink Ignite, the VAN accessory, permanent J-codes, and a dedicated hospital sales team. For 2026 Heron plans higher commercial investment while remaining EBITDA positive , guiding $173–$183 million in net product sales and $10–$20 million adjusted EBITDA, and expects a potential ZYNRELEF prefilled-syringe approval in mid-late 2027. Interested in Heron Therapeutics, Inc.? Here are five stocks we like better. Heron Therapeutics (NASDAQ:HRTX) reported fourth-quarter and full-year 2025 results while outlining plans to increase commercial investment in 2026 to build on what management described as an inflection in acute care demand that emerged earli
Show less
Read more
Impact Snapshot
Event Time:
HRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HRTX alerts
High impacting Heron Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
HRTX
News
- Heron Therapeutics, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Heron Therapeutics: Q4 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
- Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial ResultsGlobeNewswire
HRTX
Earnings
- 2/26/26 - Beat
HRTX
Analyst Actions
- 1/9/26 - HC Wainwright
HRTX
Sec Filings
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- HRTX's page on the SEC website